Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2025-12-25 @ 1:19 AM
NCT ID:
NCT02904993
Eligibility Criteria:
Inclusion Criteria:
* Subject scheduled for Direct Anterior unilateral total hip replacement
* Weight ≥ 50 and ≤125 kg
* Intact neurological exam
* Cognitively intact with ability to sign consent
Exclusion Criteria:
* Renal insufficiency with creatinine \> 1.5 mg/dl
* Allergic to any of the following : Ropivacaine, Epinephrine, Ketorolac, Morphine sulfate, NSAIDs, Tylenol, Neurontin, Morphine, Oxycodone or Dilaudid.
* Subject taking regular narcotic medications prior to surgery (20mg/day Morphine equivalents for \>7days)
* Subject with prior open hip surgery who received regional anesthesia or periarticular injection for post op pain management.
* Subject with contraindication for spinal anesthesia
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT02904993
Study Brief:
Protocol Section:
NCT02904993